Saltro launches Directlab, a web-based service providing access to reliable STI tests

You are here


Wijnegem, Belgium, June 9th 2016: Novosanis announced today their collaboration with Saltro, an innovative diagnostic center with headquarters in Utrecht, The Netherlands. ‘Directlab’ is Saltro’s initiative to provide a better and easy accessible program to test for STIs (Sexual Transmitted Infections). Saltro chose Novosanis’ Colli-Pee™ to ensure standardized first-void urine (first 20ml of urine) self-sampling.

The first test Saltro’s Directlab offers is a Chlamydia test. Although a Chlamydia infection does not cause significant problems in the beginning it can cause complications and is highly transmittable. Therefore easy access to detect the bacteria and drive the patient to a GP for treatment is key in the prevention of spreading.

Unique to this initiative is the possibility for home-based self-sampling in an easy and first-time right manner. Novosanis Colli-Pee™ offers the solution to collect first-void urine that can be send to the lab for analysis. This way the quality of the test is guaranteed while providing the patient the needed discretion in order to motivate him or her to take the test.

Vanessa Vankerckhoven, CEO Novosanis stated: "We are pleased that Colli-Pee is part of a disruptive new solution offering home-based self-sampling for detection of STIs. We are convinced that public health will benefit from Saltro’s Directlab initiative. "

"The advantage of inclusion Colli-Pee is that it provides a standardized first-void sample which will be beneficial for the analysis of STIs. Moreover the device can easily be shipped by postal mail to the patients’ home." says Dr. Sanne van Delft, Program manager at Saltro.


For more information, please contact:

About Novosanis

Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests, vaccination based actions and the overall patient’s comfort.

We are a medical device company active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment.

Novosanis prospers in user-friendly and smart medical devices meeting all regulatory and quality requirements, solutions that can improve the accuracy of the diagnostic test while making the handling easier, more consistent and more comfortable for the person.

Currently we have two device platforms in portfolio: VAX-ID, suited for accurate intradermal injections and Colli-Pee™, suited for standardized collection of first void urine. Colli-Pee™ is in commercial stage and is CE marked.

About Saltro

Saltro is an innovative diagnostic center offering support through laboratory testing, function testing and counseling to healthcare professionals aiming to provide the best care to patients. Diagnosis is inextricably linked to diagnostics and is the basis of every treatment. Saltro organizes the assessment in close collaboration with general practitioners, midwives and hospitals to deliver the right care to patients at the right place. Patients receive at Saltro quality diagnostics, close to home and with excellent service and hospitality. For this, they can turn to about 170 locations and if necessary we come to people's homes. Moreover Saltro assists about 10,000 people with thrombosis with the use of anticoagulants.

For more information, please visit:

For more information on Directlab, please visit: